Rituxan Phase III for PPMS

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Rituxan Phase III for PPMS

Postby dignan » Tue Jan 10, 2006 4:43 pm

I thought this was a typo a week or two ago when I saw mention of the latest Rituxan trial for PPMS being a Phase III trial, but this exerpt from a press release today says it again, so I guess it's not a typo.

Genentech Announces Full Year and Fourth Quarter 2005 Results

Tuesday January 10, 4:29 pm ET

Record Annual Revenues of $6.6 Billion Drive Year-Over-Year Non-GAAP EPS Growth of 54 Percent

SOUTH SAN FRANCISCO, Calif., Jan. 10 /PRNewswire-FirstCall/

In the fourth quarter of 2005, Genentech completed enrollment in the Phase III study of Rituxan in primary progressive multiple sclerosis, as well as in the Phase II combination study of Avastin and Tarceva in non-small cell lung cancer.

User avatar
Family Elder
Posts: 1608
Joined: Wed Aug 11, 2004 3:00 pm


Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service